The Gynecologic Oncology Group
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1970-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.gog.org
Radiation Therapy, Paclitaxel, and Cisplatin in Treating Patients With Cancer of the Cervix
- Conditions
- Cervical Cancer
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-02-04
- Lead Sponsor
- Gynecologic Oncology Group
- Target Recruit Count
- 29
- Registration Number
- NCT00003377
- Locations
- 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, United States
🇺🇸Cleveland Clinic Cancer Center at Fairview Hospital, Cleveland, Ohio, United States
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
- Conditions
- Adult Type Ovarian Granulosa Cell TumorOvarian GynandroblastomaOvarian Sex Cord Tumor With Annular TubulesOvarian Sertoli-Leydig Cell TumorOvarian Steroid Cell Tumor
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2020-03-05
- Lead Sponsor
- Gynecologic Oncology Group
- Target Recruit Count
- 31
- Registration Number
- NCT00006227
- Locations
- 🇺🇸
Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View, California, United States
🇺🇸University of Mississippi Medical Center, Jackson, Mississippi, United States
🇺🇸Rush University Medical Center, Chicago, Illinois, United States
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer
- Conditions
- Endometrial Serous AdenocarcinomaStage III Uterine Corpus CancerEndometrial Clear Cell AdenocarcinomaEndometrial AdenocarcinomaStage IV Uterine Corpus Cancer
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2014-12-31
- Lead Sponsor
- Gynecologic Oncology Group
- Target Recruit Count
- 31
- Registration Number
- NCT00005830
- Locations
- 🇺🇸
Gynecologic Oncology Group, Philadelphia, Pennsylvania, United States
Nitrocamptothecin in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer
- Conditions
- Ovarian CancerPrimary Peritoneal Cavity Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-07-09
- Lead Sponsor
- Gynecologic Oncology Group
- Registration Number
- NCT00006267
Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus
- Conditions
- Sarcoma
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-07-09
- Lead Sponsor
- Gynecologic Oncology Group
- Target Recruit Count
- 166
- Registration Number
- NCT00003128
- Locations
- 🇺🇸
CCOP - Carle Cancer Center, Urbana, Illinois, United States
🇺🇸CCOP - Northern Indiana CR Consortium, South Bend, Indiana, United States
🇺🇸Tufts - New England Medical Center, Boston, Massachusetts, United States
Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the Vulva
- Conditions
- LymphedemaPerioperative/Postoperative ComplicationsVulvar Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-07-09
- Lead Sponsor
- Gynecologic Oncology Group
- Registration Number
- NCT00028951
- Locations
- 🇺🇸
CCOP - Central Illinois, Decatur, Illinois, United States
🇺🇸Saint Joseph Regional Medical Center, South Bend, Indiana, United States
🇺🇸CCOP - Cancer Research for the Ozarks, Springfield, Missouri, United States
EF5 to Detect Tumor Hypoxia in Patients With Stage IIB, Stage IIIB, or Stage IVA Cervical Cancer
- Conditions
- Cervical Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-06-24
- Lead Sponsor
- Gynecologic Oncology Group
- Registration Number
- NCT00049231
- Locations
- 🇺🇸
Cancer Care Associates - Midtown Tulsa, Tulsa, Oklahoma, United States
🇺🇸Colorado Gynecologic Oncology Group P.C., Denver, Colorado, United States
🇺🇸Arkansas Cancer Research Center at University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
Dactinomycin in Treating Patients With Persistent or Recurrent Gestational Trophoblastic Neoplasia
- Conditions
- Gestational Trophoblastic Tumor
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-06-10
- Lead Sponsor
- Gynecologic Oncology Group
- Registration Number
- NCT00003688
- Locations
- 🇳🇴
Norwegian Radium Hospital, Oslo, Norway
🇺🇸Charles M. Barrett Cancer Center at University Hospital, Cincinnati, Ohio, United States
🇺🇸Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States
Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia
- Conditions
- Good Prognosis Metastatic Gestational Trophoblastic TumorHydatidiform MoleNon-Metastatic Gestational Trophoblastic TumorUterine Corpus Choriocarcinoma
- Interventions
- Biological: Dactinomycin
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2018-05-15
- Lead Sponsor
- Gynecologic Oncology Group
- Target Recruit Count
- 240
- Registration Number
- NCT00003702
- Locations
- 🇺🇸
Gynecologic Oncology Group, Philadelphia, Pennsylvania, United States
Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer
- Conditions
- Endometrial Serous AdenocarcinomaStage III Uterine Corpus CancerEndometrial Adenosquamous CarcinomaEndometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation
- Interventions
- Biological: FilgrastimBiological: Pegfilgrastim
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2015-05-19
- Lead Sponsor
- Gynecologic Oncology Group
- Target Recruit Count
- 659
- Registration Number
- NCT00006011
- Locations
- 🇺🇸
Gynecologic Oncology Group, Philadelphia, Pennsylvania, United States